In the HCV-negative cohort (n = 103): CD68/CD163 ratio maintained significant predictive value for thrombosis (OR = 1.64, 95% CI:1.119–2.404, p = 0.011) in the HCV-negative cohort, confirming the robustness of our findings independent of viral hepatitis status. The gene discussed is CD163; the disease is viral hepatitis.